Pahlavan Payam Samareh, Feldmann Robert E, Zavos Christos, Kountouras Jannis
Department of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany.
J Surg Res. 2006 Aug;134(2):238-51. doi: 10.1016/j.jss.2005.12.011. Epub 2006 Feb 3.
The fascinating aspect of the liver is the capacity to regenerate after injury or resection. A variety of genes, cytokines, growth factors, and cells are involved in liver regeneration. The exact mechanism of regeneration and the interaction between cells and cytokines are not fully understood. There seems to exist a sequence of stages that result in liver regeneration, while at the same time inhibitors control the size of the regenerated liver. It has been proven that hepatocyte growth factor, transforming growth factor, epidermal growth factor, tumor necrosis factor-alpha, interleukins -1 and -6 are the main growth and promoter factors secreted after hepatic injury, partial hepatectomy and after a sequence of different and complex reactions to activate transcription factors, mainly nuclear factor kappaB and signal transduction and activator of transcription-3, affects specific genes to promote liver regeneration. Unraveling the complex processes of liver regeneration may provide novel strategies in the management of patients with end-stage liver disease. In particular, inducing liver regeneration should reduce morbidity for the donor and increase faster recovery for the liver transplantation recipient.
肝脏的迷人之处在于其在损伤或切除后具有再生的能力。多种基因、细胞因子、生长因子和细胞参与肝脏再生。再生的确切机制以及细胞与细胞因子之间的相互作用尚未完全明确。似乎存在一系列导致肝脏再生的阶段,与此同时,抑制剂控制着再生肝脏的大小。已经证实,肝细胞生长因子、转化生长因子、表皮生长因子、肿瘤坏死因子-α、白细胞介素-1和-6是肝损伤、部分肝切除后分泌的主要生长和促进因子,经过一系列不同且复杂的反应激活转录因子,主要是核因子κB和信号转导及转录激活因子-3,影响特定基因以促进肝脏再生。阐明肝脏再生的复杂过程可能为终末期肝病患者的治疗提供新策略。特别是,诱导肝脏再生应能降低供体的发病率,并使肝移植受者更快康复。